NHS National Generic Pharmaceuticals Wave 13

Cancelled

Buyers

Value

£469,741,550

Classifications

  • Pharmaceutical products

Tags

  • tenderCancellation

Submission Deadline

3 years ago

Published

2 years ago

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13
Offer reference number: CM/PHG/17/5532
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

Transition (Everolimus)
CESW: 1 March 2022 - 30 September 2023 (19 months)
LSNE: 1 March 2022 - 31 January 2023 (11 months)
NWLN: 1 March 2022 - 31 January 2023 (11 months)

Oral Products plus non-parenterals
All Regions: 1 March 2022 - 31 May 2024 (27 months)

Hospital Only Products
CESW: 1 February 2022 - 30 September 2023 (20 months)
LSNE: 1 February 2022 - 31 May 2024 (28 months)
NWLN: 1 February 2022 - 31 January 2023 (12 months)

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Biologic and Biosimilar Medicines

Procurement for the provision of Biologic and Biosimilar Medicines.

Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)

Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)

Published 4 days ago
Open

NP49024 Growth Hormone

This Framework Agreement is for the supply of Growth Hormone to health boards across NHS Scotland.

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Published 1 week ago
Open

Pralidoxime chloride 2024

This procurement exercise is for a contract(s) for the provision of pralidoxime chloride for injection, which are to be held in the emergency planning stockpile to be deployed in certain emergency situations. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The awarding of lots is not appropriate for this product due to the nature of the product involved. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: [email protected]

Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency

Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency

Published 2 weeks ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

ATAMIS LTD

Business and domestic software development

Gemma Tomlinson/Lynne Tierney

[email protected]

Timeline cancelled